---
title: "KKR reportedly assigned almost 60% of BridgeBio stock sale to five firms"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295952835.md"
description: "KKR allocated nearly 60% of its BridgeBio Pharma (BBIO) secondary share sale to five major investors. The offering of 5 million shares, priced at $28 each, generated over $387 million in gross proceeds for KKR. Demand significantly exceeded supply, with allocations favoring long-only and healthcare-focused funds."
datetime: "2026-08-14T15:20:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295952835.md)
  - [en](https://longbridge.com/en/news/295952835.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295952835.md)
generator: "portal-rs"
---

# KKR reportedly assigned almost 60% of BridgeBio stock sale to five firms

Nearly 60% of KKR’s (KKR) sale of BridgeBio Pharma (BBIO) shares was allocated to the five biggest investors who took part in the offering, Bloomberg reported on Friday, citing people familiar with the matter. Palo Alto, California-based BridgeBio (BBIO) on Thursday announced the secondary offering of 5M shares by KKR Genetic Disorder L.P., with Wi...

### Related Stocks

- [BBIO.US](https://longbridge.com/en/quote/BBIO.US.md)
- [KKR.US](https://longbridge.com/en/quote/KKR.US.md)
- [KKR-D.US](https://longbridge.com/en/quote/KKR-D.US.md)
- [KKRS.US](https://longbridge.com/en/quote/KKRS.US.md)
- [KKRT.US](https://longbridge.com/en/quote/KKRT.US.md)

## Related News & Research

- [Here's How Much $1000 Invested In KKR 10 Years Ago Would Be Worth Today](https://longbridge.com/en/news/296804066.md)
- [Key facts: KKR & Co Inc in megadeals; preferred for Avisena; BookMyShow](https://longbridge.com/en/news/296316418.md)
- [KKR Acquires Leading Japanese Beauty Platform Ci FLAVORS | KKR Stock News](https://longbridge.com/en/news/296857373.md)
- [KKR to Acquire Japan Haircare, Skincare Company Ci Flavors](https://longbridge.com/en/news/296868358.md)
- [Steadfast Enters Into Scheme Implementation Deed with KKR, Others](https://longbridge.com/en/news/296591904.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**